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The British government is boosting
access to genetic services available to
patients through its National Health
Service but also plans to intervene to
stop the growth of a potentially
uninsurable genetic underclass in the
face of growing concerns about the
speed of developments. Last month,
a committee of MPs called for a two-
year moratorium on the use of further
genetic tests by insurers to allow
time for the proper assessment of the
implications.
The government has so far
approved only one genetic test, for
Huntington’s disease, and although
the British insurance industry has
handled only a small number of cases
involving genetic testing, cases are
likely to soar over the next decade as
more tests are developed and there
are widespread concerns about the
insurance industry’s approach to the
issues.
In a critical report on the secrecy,
irresponsibility and ineptitude of the
insurance industry’s handling of such
a sensitive subject, the MPs accuse
insurance firms of misleading them
over the extent to which they were
already using test results to assess
premiums.
The cross-party science select
committee accuses insurers of being
“far more interested in establishing
their future right to use genetic test
results in assessing premiums, than
in whether or not they are reliable or
relevant.” The MPs also attack the
government for failing to regulate,
leading to an ‘atmosphere of
confusion and ignorance’. It also
warns that regulatory bodies are
either under-funded or
inappropriately contain
representatives from the insurance
industry.
During the inquiry, two insurance
companies changed their evidence
and admitted they were using tests
not approved by the government’s
Genetics and Insurance Committee
(GIAC) which regulates the field.
“Many insurance companies have
failed to make their policy on the use
of tests clear and have given the
impression that they do not want
people to know what they are doing,
or do not fully understand their own
policy,” said Michael Clark, chairman
of the committee of MPs.
High-risk subscribers should be
able to receive protection from a
reinsurance pool, probably
through some form of
government subsidy
The Human Genetics Commission, a
body charged with advising
ministers, is already studying the
future of insurance. It is likely to
recommend that high-risk
subscribers should be able to receive
protection from a reinsurance pool,
probably through some form of
government subsidy. 
The commission looked at
reinsurance as a ‘middle way’
between public opposition to
companies having any access to tests
and the companies’ contrary view.
The government is already aware of
some of the problems in this
controversial policy area. It has
already warned that advances in
genetics will in the foreseeable
future increase the premiums of
high-risk subscribers. Ministers may
make a regulatory distinction
between ‘essentials’ such as life
insurance needed for mortgage cover,
where genetic discrimination could
have disastrous consequences and
‘luxuries’ such as extensive private
health insurance, where patients
could rely on the NHS instead.
The MPs say the Association of
British Insurers (ABI), which has
drawn up a code of practice in this
area, “must act as a matter of urgency
to convince the public and
government that the code of practice
is being complied with”. They point
out that some companies are not
signatories to the code.
So far GAIC has only given
permission for life insurers to use test
results for assessing the risk of
Huntington’s disease. It is also
studying applications for familial
early onset Alzheimer’s disease.
But the insurance companies
have insisted wider tests can be used
before their approval or otherwise by
the GAIC. The committee demands
that the “insurance companies
should immediately cease to use the
positive results from any genetic test
that has not been explicitly approved
by the GAIC”. The MPs warn that
polls showed that only 7% of the
country believed insurance
companies could be trusted to use
genetic data responsibly.
However, the committee opposes
an outright ban on use of all genetic
information by insurers, as this
would deny those with a problematic
family history but a good genetic test
result the opportunity of obtaining
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insurance on a standard rating. In
calling for the two-year moratorium
on the use of genetic tests the
committee says that this will provide
time “for more research on the
actuarial and scientific relevance of
genetic test results for use by the
insurance industry”. The ABI
responded by saying it was already
reviewing its code and would never
ask anyone to take a genetic test to
obtain insurance. It added: “Insurers
can only ask to see existing genetic
test results where medical experts
have identified the test as reliable
and relevant for insurance
purposes”.
The MPs still feel there is time for
the insurers to change their
behaviour before legislation forces
their hand. “We now look to the
insurance industry to act
responsibly,” says Clark. “We believe
that insurers can well afford to ignore
genetic test results for the forseeable
future”. 
The health secretary, Alan
Milburn, announcing the extra
resources for genetic services, said
that the job was to prepare for change
so as to harness the benefits of
genetics discoveries. “To avoid the
dangers we need to secure public
approval for progress too.”
